Synthetic biology specialist GRO Biosciences is exploring strategic alternatives about six months after raising a series B ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...

For baby boomers, ultra-safe dividend stocks like these five that can add passive income streams to Social Security benefits.

Burning Rock Biotech Limited’s BNR share price has dipped by 13.43%, which has investors questioning if this is right time to buy.

Bayer BAYRY announced its fourth-quarter and full-year 2024 results. AbbVie ABBV announced a licensing deal with Danish firm ...

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

AbbVie made a $350 million upfront payment to Gubra for rights to the drug, called GUB014295. Gubra is also eligible to receive another $1.9 billion if certain development and sales milestones are met ...

According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.

Dassault Aviation could cut its aircraft manufacturing workload at its Little Rock facility, located in the U.S. state of Arkansas, if President Trump goes ahead with his threat to impose a 25% tariff ...